Wozniak, Krystyna M. et al
"The Orally Active Glutamate Carboxypeptidase II Inhibitor E2072 Exhibits Sustained Nerve Exposure and Attenuates Peripheral Neuropathy." Journal of Pharmacology and Experimental Therapeutics
343.3
(2012):
746-754.
Web. 04 Mar. 2021.
